Brian Manning

Company: 28bio

Job title: Director of Business Development

Seminars:

Rethinking Peripheral Neuropathy Models: A Human Approach to Preclinical Testing 10:00 am

Preclinical drug development often fails due to poor translation from animal models to human physiology Peripheral neuropathy is difficult to assess using 2D cell cultures or animal models, as they fail to replicate 3D nerve structure and functional electrophysiology To address this, 28bio developed PNS-3D technology, a human, complex in vitro organoid model designed for…Read more

day: Scientific Program Day Two